Testicular sarcoidosis is a rare but benign entity. It is often mistaken for testicular neoplasm, leading to orchiectomy. It is, therefore, extremely important to identify and correctly diagnose testicular sarcoidosis on sonography to avoid unnecessary orchiectomy. This case study reports a young patient who had a prior history of unilateral orchiectomy for cryporchidism and presented with testicular lesions on the contralateral testis. He was later found to have skin lesions and chest symptoms that led to a diagnosis of sarcoidosis.
Sarcoidosis is an uncommon idiopathic multisystemic disorder of unknown pathogenesis, characterized histologically by the formation of noncaseating granulomas within involved organs. The most commonly involved organs are the lungs, the skin, and the eyes. Involvement of the male genitourinary organs, most commonly in the epididymis followed by the testes, is very rare and reported to be <0.2% in clinically diagnosed cases. 1 Testicular and epididymal sarcoidosis usually coexist, and isolated involvement of the testis, as in this case, is very rare.
At imaging, sarcoidosis of the testes may mimic testicular malignancy, but sonography of the scrotum can suggest a diagnosis of sarcoidosis in the presence of underlying constitutional symptoms, negative tumor markers, and chest radiographic findings. Awareness of the presence and association of hypoechoic testicular lesions with sarcoidosis, especially in those patients who have a preexisting diagnosis of systemic sarcoidosis or clinicopathological findings strongly suggesting this disease, plays a vital role in suggesting the proper diagnosis.
Case Report
A white man in his late 20s presented to the emergency department with one week of left scrotal pain. His past medical history was remarkable for right orchiectomy as an infant secondary to cryptorchidism, gastroesophageal reflux, and smoking. The patient denied any fever, weight loss, night sweats, hemoptysis, or exposure to tuberculosis and had no recent travel history or human immunodeficiency virus.
Physical examination on admission revealed left testicular tenderness and a palpable mass without inguinal or cervical lymphadenopathy. The patient was referred for a sonographic examination to rule out intratesticular neoplasm or infection.
Sonographic examination of the scrotum using an ML 6-to 15-MHz linear array transducer (GE Logic 9; GE Healthcare, Waukesha, Wisconsin) revealed a right scrotal prosthesis ( Figure 1) ; several well-defined, round, hypoechoic left testicular masses; and peripheral microlithiasis ( Figure 2 ). The largest of the masses measured 5 × 5 × 4 mm and showed the presence of internal vascularity ( Figure 3 ). A small hydrocele was noted around the left testicle. The left epididymis was of normal size and contained small cysts.
Testicular tumor markers, including B-human chorionic gonadotropin and α-fetoprotein, lactate dehydrogenase (LDH), and SMA-12, were normal.
The differential diagnosis for these testicular lesions included lymphoma, leukemia, seminoma, and sarcoidosis granuloma. Management options, including surgical exploration, were discussed with the patient. The patient elected to have surgical intervention to confirm the histopathology of these lesions.
Within one month and during the preoperative period, the patient presented to the emergency department because of a steadily worsening left scrotal pain, fatigue, chest pain, hypercalcemia, vision changes, and back skin nodules. A repeat sonographic examination revealed a slight decrease in the size of the largest lesion compared with the initial sonographic examination. Other sonographic findings were unchanged.
A chest radiograph demonstrated bilateral hilar and mediastinal lymphadenopathy and interstitial infiltrates ( Figure 4 ). Biopsy of the back skin lesions revealed cutaneous inflammatory granulomas. A diagnosis of sarcoidosis was made on the basis of the clinical, histologic, and chest radiograph findings.
After consultation with pulmonary specialists, the patient underwent an intravenous fluid hydration and was started on prednisone and hydroxychloroquine (Plaquemil). His hypercalcemia improved within two days, and the patient was discharged in a stable condition. After two months of corticosteroid therapy, the patient returned to the hospital for follow-up. The patient's symptoms had improved. A repeat chest radiograph showed normalization and resolution of the lymphadenopathy and the interstitial changes. However, the testicular findings remained essentially unchanged, with no significant change in the size of the lesions but slightly poorly defined margins compared with the prior sonographic examination.
Because of the limited response of the testicular lesions to the corticosteroid therapy, the presence of peripheral testicular microlithiasis, and the patient's concern about malignancy, a high inguinal and incisional biopsy of two of the testicular lesions was performed, which revealed fibrosis. However, the results were still inconclusive for malignancy exclusion. Consequently and based on the patient's presurgical consent for orchiectomy if results were indeterminate, a radical left orchiectomy was performed, and the patient's recovery was uneventful.
Histopathologic examination of the specimen showed multifocal intraparenchymal foci of fibrosis with hemosiderin deposition, scattered giant cells, and noncaseating granulomas consistent with sarcoidosis. Postoperatively, the patient was placed on steroid therapy.
Discussion
Sarcoidosis is an uncommon idiopathic multisystemic disorder of unknown pathogenesis, characterized histologically by the formation of noncaseating granulomas within involved organs. [2] [3] [4] [5] Despite its unknown etiology, it has been suggested that sarcoidosis may result from overreacting immune response of the type 1 T helper cells to toxic agents such as insecticides and environmental organic dust, 6 musty-smelling work environments, 7 rural living, 8 genetic factors, 9, 10 metal vapors or dust, 11 microbiological agents, 12 and mycobacterial tuberculosis. 13 Sarcoidosis has been reported to occur anywhere in the body. 14, 15 The most commonly involved organs are the lungs, the skin, and the eyes. 14, 16 The central nervous, muscular, genitourinary, and lymphatic systems as well as the heart, salivary glands, and joints have been reported to be affected. 17 Its incidence is reported to be 1 to 6 in 100,000 cases worldwide. 18 Involvement of the male genitourinary system is exceedingly rare and reported to be <0.2% in clinically diagnosed cases and 5% of those diagnosed at autopsy. 1, 19 Fewer than 80 cases have been reported in the literature. 17, 20 It affects African American men 10 to 20 times more than white men, and most patients present with symptoms between the second and fourth decades of life, which coincides with the peak incidence of testicular neoplasia. 19, 21, 22 Sarcoidosis in the genitourinary system most frequently occurs in the epididymis, followed by the testes, spermatic cord, prostate, scrotum, and penis. 19, [23] [24] [25] [26] [27] [28] In a study of 60 cases of sarcoidosis involving the male reproductive system, Kodama et al. 17 found that 73% of the cases involved the epididymis, 47% the testes, 8% the spermatic cord, and 3% the prostate gland.
Sarcoidosis of the testes as a presenting feature is rare. 29 It was first described in the literature in 1936 by Schaumann. 30 Testicular sarcoidosis is usually associated with epididymal sarcoidosis, but it has been reported as an isolated disease and without any epididymal involvement or infiltration. 29, 31 In this case, the patient did not have any epididymal involvement. Sixty percent of cases with generalized sarcoidosis present with pulmonary symptoms such as chronic dry cough, dyspnea, and chest pain as the chief complaints. 32 Symptoms of fatigue, weight loss, myalgia, sweating, muscle weakness, exercise intolerance, and anorexia have also been reported in more than 40%. 33 In addition, Lofgren syndrome-the combination of bilateral hilar lymphadenopathy, erythema nodosum, fever, and polyarthralgia-has been identified in 20% to 50% of sarcoidosis cases. 34, 35 Most patients with testicular sarcoidosis may present with a painless nodular and diffuse intrascrotal mass on palpation. 36 Other symptoms, such as mild pain and scrotal swelling, have been reported. 36, 37 By sonography, patients with testicular sarcoidosis may present with a single hyperechoic or homogeneous mass, although more commonly they present with multiple bilateral hypoechoic lesions with or without epididymal involvement. [38] [39] [40] [41] [42] In this case, the patient had multiple hypoechoic lesions throughout the solitary left testes with microlithiasis. Based on the patient's initial absence of symptomatic systemic manifestations of sarcoidosis, history of cryptorchidism, age, race, presence of microlithiasis, and failure to respond to corticosteroid therapy, malignancy could not be ruled out. Many reports have associated cryptorchidism, 43 microlithiasis, 44, 45 age, 46 and race 47 with testicular malignancy. The subsequent development of the clinical manifestations of the disease, the presence of normal tumor markers, and the presence of bilateral lymphadenopathy on chest x-rays in this patient favored the diagnosis of sarcoidosis. However, the atypical clinical findings of previous right orchiectomy, noninvolvement of the epididymis, and limited response of lesions to therapy made the exclusion of malignancy not possible. Coexistence of sarcoidosis and malignancy has been reported. [47] [48] [49] In a study at the Mayo Clinic over 46 years, Rayson et al. 46 found the incidence of testicular carcinoma among patients with sarcoidosis to be 625.5 per 100,000 and the incidence of sarcoidosis in patients with testicular carcinoma to be 617.3 per 100,000. Furthermore, Rayson et al. 46 indicated that the incidence of testicular cancer in patients with sarcoidosis was 100 times the expected rate.
Therapy for testicular sarcoidosis is controversial. Many patients with sarcoidosis show spontaneous resolution over a period of up to three years. 49 However, patients with unresolving sarcoidosis are placed on corticosteroid therapy, especially if vital organ function is affected and hypercalcemia is present. 50, 51 In general, corticosteroids have been reported to be effective in reducing the size of testicular lesions and improving the metabolic and symptomatic manifestations of sarcoidosis. 50, 52 In cases where corticosteroid therapy fails to control the symptoms or halt the progression of the disease, surgical intervention may become warranted. In addition, methotrexate, a cytogenic agent, has been used to treat sarcoidosis. 16 In patients with known sarcoidosis and a testicular carcinoma, several approaches have been approved: intraoperative biopsy, 53 bilateral orchiectomy for bilateral lesions, 54 radical orchiectomy for unilateral testicular involvement, 55 unilateral orchiectomy for bilateral testicular lesions, 55 and empiric steroid therapy. 50 Overall, the treatment of testicular sarcoidosis must be tailored to each patient and the severity of the disease as well as to the preservation of the patient's fertility if future conception is desired.
Conclusion
Testicular sarcoidosis is a benign entity, and a definite diagnosis can be made if a patient has a typical sonographic appearance, including bilateral testicular (and sometimes associated with epididymal) hypoechoic lesions, in the absence of positive tumor markers. The presence of associated findings such as hilar and mediastinal lymphadenopathy on a chest radiograph can further confirm the diagnosis. Testicular sarcoidosis can mimic testicular malignancy, and for that reason, it is extremely important for sonographers, sonologists, or radiologists to correctly identify testicular sarcoidosis and differentiate it from testicular malignancy by thoroughly reviewing the patient's medical history, radiological manifestations (if any), and clinical, pathological, and laboratory values to prevent unnecessary orchiectomy.
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